Clinicopathologic Factors Associated with Readmissions and ED Visits after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)

Authors

  • Erin Rauber, B.A., Jill Haley, B.A., Jordan Baker, M.S., Julie Ann Broski, Ph.D., Mazin Al-Kasspooles, M.D., FACS

DOI:

https://doi.org/10.17161/kjm.vol17.22700

Metrics

Metrics Loading ...

Downloads

Published

2024-08-27

Issue

Vol. 17 No. S2 (2024): Supplement 2: Abstracts from the 2024 KUMC Student Research Forum

Section

Abstracts

License

Copyright (c) 2024 Erin Rauber, B.A., Jill Haley, B.A., Jordan Baker, M.S., Julie Ann Broski, Ph.D., Mazin Al-Kasspooles, M.D., FACS

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Erin. (2024). Clinicopathologic Factors Associated with Readmissions and ED Visits after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC). Kansas Journal of Medicine, 17(S2), 65. https://doi.org/10.17161/kjm.vol17.22700